Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hoff

Showing results (21-30 of 514) with videos related to

Pageof 52
Sort By:
Clinical Colorectal Cancer|July 6, 2012
Antiangiogenic drugs for colorectal cancer: exploring new possibilitiesRenata Ferrarotto, Paulo M Hoff
Oncology (Williston Park, N.Y.)|June 25, 2004
Progress in the development of novel treatments for colorectal cancerPaulo M Hoff, Richard Pazdur
Oncology (Williston Park, N.Y.)|March 1, 2006
Cytotoxic chemotherapy for advanced colorectal cancer. Recent advances in managementScott Kopetz, Paulo M Hoff
Expert Opinion on Pharmacotherapy|August 10, 2005
Angiogenesis inhibitors in the treatment of cancerJay Rhee, Paulo M Hoff
Oncology|November 20, 2010
Bevacizumab plus irinotecan-based regimens in the treatment of metastatic colorectal cancerVolker Heinemann, Paulo M Hoff
Seminars in Oncology|July 13, 2000
Dihydropyrimidine dehydrogenase inhibitory fluoropyrimidines: a novel class of oral antineoplastic agentsP M Hoff, R Pazdur
Hematology/Oncology Clinics of North America|June 6, 2007
Medullary thyroid carcinomaAna O Hoff, Paulo M Hoff
Diseases of the Colon and Rectum|January 26, 2007
Evidence of clinical activity for cetuximab combined with irinotecan in a patient with refractory anal canal squamous-cell carcinoma: report of a caseLan K Phan, Paulo M Hoff
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2007
Targeted therapy trials: approval strategies, target validation, or helping patients?Paulo M Hoff, Lee M Ellis
Journal of the Air & Waste Management Association (1995)|July 17, 2009
Remote sensing of particulate pollution from space: have we reached the promised land?Raymond M Hoff, Sundar A Christopher
Pageof 52

Showing results (21-30 of 514) with videos related to

Sort By:
Pageof 52
Clinical Colorectal Cancer|July 6, 2012
Antiangiogenic drugs for colorectal cancer: exploring new possibilitiesRenata Ferrarotto, Paulo M Hoff
Oncology (Williston Park, N.Y.)|June 25, 2004
Progress in the development of novel treatments for colorectal cancerPaulo M Hoff, Richard Pazdur
Oncology (Williston Park, N.Y.)|March 1, 2006
Cytotoxic chemotherapy for advanced colorectal cancer. Recent advances in managementScott Kopetz, Paulo M Hoff
Expert Opinion on Pharmacotherapy|August 10, 2005
Angiogenesis inhibitors in the treatment of cancerJay Rhee, Paulo M Hoff
Oncology|November 20, 2010
Bevacizumab plus irinotecan-based regimens in the treatment of metastatic colorectal cancerVolker Heinemann, Paulo M Hoff
Seminars in Oncology|July 13, 2000
Dihydropyrimidine dehydrogenase inhibitory fluoropyrimidines: a novel class of oral antineoplastic agentsP M Hoff, R Pazdur
Hematology/Oncology Clinics of North America|June 6, 2007
Medullary thyroid carcinomaAna O Hoff, Paulo M Hoff
Diseases of the Colon and Rectum|January 26, 2007
Evidence of clinical activity for cetuximab combined with irinotecan in a patient with refractory anal canal squamous-cell carcinoma: report of a caseLan K Phan, Paulo M Hoff
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2007
Targeted therapy trials: approval strategies, target validation, or helping patients?Paulo M Hoff, Lee M Ellis
Journal of the Air & Waste Management Association (1995)|July 17, 2009
Remote sensing of particulate pollution from space: have we reached the promised land?Raymond M Hoff, Sundar A Christopher
Pageof 52